# Michael D. Taylor

Source: https://onco.cc/people/michael-taylor/  
OnCo record `michael-taylor` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Neurosurgeon-scientist who defined the four molecular subgroups of medulloblastoma that now guide therapy.

## Summary

Michael Taylor led the international consensus that divided medulloblastoma into WNT, SHH, Group 3 and Group 4 subgroups, a classification adopted by the WHO that underpins current risk-stratified and de-escalated treatment trials. His laboratory showed that medulloblastoma metastases diverge genetically from the primary tumour and that the tumours spread via blood. He moved from SickKids Toronto to Texas Children's in 2023.

## Fields

- Kind: Person
- Last checked: 2026-09-10
- Tags: paediatric; medulloblastoma; genomics
- Role: Professor of Pediatrics and Neurosurgery, Baylor College of Medicine and Texas Children's Hospital
- Specialisms: Medulloblastoma; Paediatric neurosurgery; Brain tumour genomics; Metastasis biology

## Sources

- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Taylor%20MD%5BAuthor%5D%20medulloblastoma

## Connected records

- cancers: [Medulloblastoma](https://onco.cc/cancers/medulloblastoma/)
- technologies: [DNA methylation profiling](https://onco.cc/technologies/methylation-profiling/), [Whole-exome & whole-genome sequencing](https://onco.cc/technologies/wes-wgs/)
- institutions: [Texas Children's Cancer and Hematology Center](https://onco.cc/institutions/texas-childrens/)
- journals: [Cancer Cell](https://onco.cc/journals/cancer-cell/)

---
JSON: https://onco.cc/api/v1/entities/michael-taylor.json